Cylert Lawyers
WASHINGTON - A drug that has been used for attention deficit hyperactivity disorder for 30 years is being discontinued.
The consumer group Public Citizen petitioned the Food and Drug Administration on Thursday, asking the agency to ban pemoline, also sold under the trade name Cylert, because of reported cases of liver damage in users.
Abbott Laboratories, the manufacturer of Cylert, said it is already planning to discontinue the drug because of declining sales.
Pemoline was approved in 1975. Since then other drugs, including generics, have become available to treat ADHD. Cylert sales were less than $1 million last year.
Read More
|
|